Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases

BACKGROUND: Hepatic steatosis commonly occurs in some chronic liver diseases and may affect disease progression. AIM: To investigate the performance of controlled attenuation parameter (CAP) for the diagnosis of hepatic steatosis in patients with autoimmune liver diseases (AILDs). METHODS: Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Xi-Xi, Lian, Min, Wu, Hui-Min, Li, Xiao-Yun, Sheng, Li, Bao, Han, Miao, Qi, Xiao, Xiao, Guo, Can-Jie, Li, Hai, Ma, Xiong, Hua, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789069/
https://www.ncbi.nlm.nih.gov/pubmed/33505152
http://dx.doi.org/10.3748/wjg.v27.i1.80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789069/
https://www.ncbi.nlm.nih.gov/pubmed/33505152
http://dx.doi.org/10.3748/wjg.v27.i1.80

Ejemplares similares